In the relentless hunt for standout stocks during earnings season, investors have their eyes on GlycoMimetics, Inc. GLYC. This company appears to be one to watch closely as it gears up to release its earnings report.
The murmurs in the financial corridors suggest a favorable wind blowing in GlycoMimetics’ direction. Why, you ask? Well, the recent activities around earnings estimates paint an optimistic picture. Analysts have been inching their estimates higher in anticipation of the upcoming report— a trend that often precedes an earnings beat.
Lurking beneath the surface of these estimations is a significant detail – the Most Accurate Estimate for the current quarter is hovering tighter than the broader Zacks Consensus Estimate, which stands at a loss of 15 cents per share. This development hints at a recent uptick in analyst projections for GLYC, giving the stock a Zacks Earnings ESP of +1.64% as we head into the earnings spectacle.
The Tale of Price and EPS Surprise at GlycoMimetics, Inc.
GlycoMimetics, Inc. price-eps-surprise | GlycoMimetics, Inc. Quote
The Significance Explained
A glowing Zacks Earnings ESP holds immense power, possessing the capability to usher in pleasant surprises and outperform the market at large. A look back over the past decade reveals that stocks with a positive Earnings ESP and a Zacks Rank #3 (Hold) or better have notched a positive surprise close to 70% of the time.
Given GlycoMimetics’ current Zacks Rank #3 standing and its optimistic ESP, it wouldn’t be outlandish for investors to give this stock a closer look before the earnings reveal. In the realm of stocks, the company is not a lonely ranger – there are others marked as Zacks #1 Rank (Strong Buy) selections as well.
From the whispers on Wall Street, it’s becoming increasingly clear that GlycoMimetics has some good headed its way. A positive outcome, perhaps a beat, could be in the cards when the much-anticipated report is unveiled.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. Previous recommendations have soared +143.0%, +175.9%, +498.3%, and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, offering a golden opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
GlycoMimetics, Inc. (GLYC): Access the Free Stock Analysis Report Here
For further insights, read the complete article on Zacks.com by clicking here.
Find out more about Zacks Investment Research here.
The musings and insights shared in this article belong solely to the author and do not necessarily mirror the stance of Nasdaq, Inc.
